Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Palvella Therapeutics, Inc. (PVLA) had Weighted-Average Shares Outstanding (Diluted) of 2.23M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-17.43M |
|
-- |
|
-- |
|
$14.10M |
|
$-14.10M |
|
$-3.34M |
|
$-17.43M |
|
$-17.43M |
|
$-17.43M |
|
$-17.43M |
|
$-17.43M |
|
$-17.43M |
|
$-14.10M |
|
$-14.10M |
|
2.23M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.23M |
$-7.83 |
|
$-7.83 |
|
| Balance Sheet Financials | |
$88.23M |
|
-- |
|
-- |
|
$88.23M |
|
$12.04M |
|
-- |
|
$13.59M |
|
$25.63M |
|
$62.61M |
|
$62.61M |
|
$62.61M |
|
11.01M |
|
| Cash Flow Statement Financials | |
$-10.84M |
|
-- |
|
$87.09M |
|
$7.35M |
|
$83.60M |
|
$76.25M |
|
$0.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.85% |
|
-27.85% |
|
-19.76% |
|
-27.85% |
|
$5.69 |
|
$-4.87 |
|
$-4.87 |
|